US 10993954 — Patent Expiration

COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US10993954

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 10993954

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

High Confidence

Application No. 16554338

December 14, 2037

11y 180d remaining

Earliest effective filing

Dec 14, 2017

+ 20 years

Dec 14, 2037

PTA +0d

Dec 14, 2037

TD cap (US 10245235)

Dec 14, 2037

Final

Dec 14, 2037

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Note: terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation Details

Base Term Calculation

Filing Date

August 28, 2019

Earliest Effective Filing

December 14, 2017

Issue Date

May 4, 2021

PTA

0 days

Base Expiry (before PTA)

December 14, 2037

December 14, 2017 + 20 years = December 14, 2037

Continuation of application 16112447, filed Aug 24, 2018, issued as US 10434113

Continuation-in-Part of application 15842580, filed Dec 14, 2017, issued as US 10245235

PRO

62520252 — Provisional — not used for base term

PRO

62435442 — Provisional — not used for base term

PRO

62520252 — Provisional — not used for base term

PRO

62435442 — Provisional — not used for base term

PRO

62520252 — Provisional — not used for base term

PRO

62435442 — Provisional — not used for base term

Terminal Disclaimer Analysis

TD Approved

1 approved, 1 filed

TD caps expiration to December 14, 2037 (earliest expiring referenced patent: US 10245235)

US 10245235(App. 15842580)

Capping Patent

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

Filing Date

Dec 14, 2017

Earliest Effective Filing

Dec 14, 2017

Issue Date

Apr 2, 2019

PTA

0 days

Calculated Expiration

Dec 14, 2037

Dec 14, 2017 + 20y = Dec 14, 2037

US 10434072(App. 16151113)

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

Filing Date

Oct 3, 2018

Earliest Effective Filing

Dec 14, 2017

Issue Date

Oct 8, 2019

PTA

0 days

Calculated Expiration

Dec 14, 2037

Divisional of 15842580, filed Dec 14, 2017, issued as US 10245235

Dec 14, 2017 + 20y = Dec 14, 2037

US 10434113(App. 16112447)

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

Filing Date

Aug 24, 2018

Earliest Effective Filing

Dec 14, 2017

Issue Date

Oct 8, 2019

PTA

0 days

Calculated Expiration

Dec 14, 2037

Continuation-in-Part of 15842580, filed Dec 14, 2017, issued as US 10245235

Dec 14, 2017 + 20y = Dec 14, 2037

US 10456367(App. 16151126)

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

Filing Date

Oct 3, 2018

Earliest Effective Filing

Dec 14, 2017

Issue Date

Oct 29, 2019

PTA

0 days

Calculated Expiration

Dec 14, 2037

Divisional of 15842580, filed Dec 14, 2017, issued as US 10245235

Dec 14, 2017 + 20y = Dec 14, 2037

US 10993954(App. 16554338)(from app 16554338)

Compositions And Methods For Treating Muscular Dystrophy And Other Disorders

Filing Date

Aug 28, 2019

Earliest Effective Filing

Dec 14, 2017

Issue Date

May 4, 2021

PTA

0 days

Calculated Expiration

Dec 14, 2037

Continuation of 16112447, filed Aug 24, 2018, issued as US 10434113

Continuation-in-Part of 15842580, filed Dec 14, 2017, issued as US 10245235

Dec 14, 2017 + 20y = Dec 14, 2037

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.